The Lovesac Company Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Narrative (Details)

Stockholders' Equity - Narrative (Details) $ / shares in Units, $ in Millions				1 Months Ended		3 Months Ended		12 Months Ended
	Jun. 26, 2023 shares	Jun. 05, 2021 d $ / shares	Jun. 29, 2018 shares	Mar. 31, 2023 shares	Jun. 30, 2019 d $ / shares shares	May 05, 2024 USD ($) $ / shares shares	Apr. 30, 2023 USD ($) $ / shares shares	Feb. 04, 2024 shares	Jan. 30, 2022 USD ($) shares
Class of Stock [Line Items]
Stock option price exercise (in dollars per share) \| $ / shares					$ 38.10
Stock options are subject to vesting percentage					100.00%
Consecutive trading days \| d		40			40
Share price (in dollars per share) \| $ / shares		$ 75			$ 75
Additional compensation \| $									$ 0.9
Modification and remaining expense was recognized \| $									$ 0.3
Number of options, exercised (in shares)						0	0
Number of options, expired (in shares)						0	0
Number of options, cancelled (in shares)						0	0
Number of options, outstanding (in shares)						495,366	495,366
Weighted average exercise price, outstanding (in dollars per share) \| $ / shares						$ 38.10	$ 38.10
Weighted average remaining contractual life, outstanding (in years)						5 years 29 days	1 year 1 month 6 days
Average intrinsic value, outstanding (in dollars per share) \| $ / shares						$ 0	$ 0
Equity based compensation expense \| $						$ 1.2	$ 0.7
Total unrecognized equity based compensation cost related to unvested stock option and restricted unit awards \| $						$ 12.6
Weighted average period						3 years 4 months 28 days
Restricted stock units \| Chief Executive Officer
Class of Stock [Line Items]
Restricted stock award grant (in shares)				235,000
Stock options
Class of Stock [Line Items]
Non statutory stock options granted (in shares)					495,366				495,366
Number of options issued (in shares)						0	0
2017 Equity Incentive Plan
Class of Stock [Line Items]
Granted term						10 years
Increase in common stock reserved for future issuance (in shares)								225,000
Common stock reserved issuance (in shares)						2,879,889
2017 Equity Incentive Plan \| Restricted stock units
Class of Stock [Line Items]
Vesting period						3 years
Roth Capital Partners, LLC \| Common Stock Warrant
Class of Stock [Line Items]
Warrants issued (in shares)	74,592		281,750
Warrants issued, term			5 years
Exercised warrants (in shares)							0
Number of warrants, warrants outstanding (in shares)						0	281,750
Average exercise price, warrants outstanding (in dollars per share) \| $ / shares							$ 19.20
Weighted average remaining contractual life (in years), warrants outstanding, beginning balance							1 month 28 days